Table 1.
Sex | |
Male | 97 (55.7%) |
Female | 77 (44.3%) |
Age (years) | |
Median (IQR) | 61 (55-69) |
Histopathological subtypes | |
NSCLC, A | 103 (59.2%) |
NSCLC, SCC | 59 (33.7%) |
NSCLC, Mixed Adeno/Squamous | 3 (1.7%) |
NSCLC undifferentiated | 9 (5.2%) |
Median overall survival | 38.4 months |
IQR, interquartile range; NSCLC, non-small cell lung cancer; SCC, squamous cell carcinoma.